Skip to main content

Table 2 Detailed characteristics of the 14 patients with PAS

From: Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma

Patient no.

Age (years)

Gender

D-dimer level

Tumor location

Tumor staging

Enhanced CT value (HU)

ΔCT value (HU)

SUVmax

MTV

TLG

OS (months)

1

57

M

N

LPA

II

66

21

7.2

26.8

114.2

3.0

2

33

F

A

RPA

I

67

26

8.0

12.1

55.0

21.0

3

69

F

N

PT, RPA, and LPA

III

76

40

16.4

7.6

62.9

0.2

4

57

M

N

PT, RPA, and LPA

III

68

21

9.8

1.0

5

40

M

A

PT

I

65

23

7.7

14.4

57.2

16.0

6

69

M

A

PT and RPA

II

67

39

13.8

11.2

90.8

10.0#

7

39

M

A

RPA

II

73

44

13.4

9.8

73.2

44.0

8

67

M

A

PT, RPA, and LPA

IV

53

19

11.3

7.5

50.0

censored

9

44

F

A

PT, RPA, and LPA

I

73

38

6.1

17.9

60.6

censored

10

52

M

A

PT, RPA, and LPA

II

63

33

10.7

23.7

142.0

11.0#

11

27

F

A

PT and LPA

IV

72

39

17.2

10.7

114.8

5.0

12

37

F

N

PT and RPA

I

31

13

3.0

5.4

10.7

15.0

13

47

M

-

PT and RPA

II

47

24

4.0

14.9

35.1

14.0

14

56

M

A

PT, RPA, and LPA

II

35

15

7.0

21.8

81.0

2.0

  1. M male, F female, N normal, A abnormal, PT pulmonary trunk, RPA right pulmonary artery, LPA left pulmonary artery, OS overall survival
  2. #To the end of December 2021